oncofarma
Trade trend analysis
Number of Transactions Quantity Weight
Number of Transactions Quantity Weight
The above chart presents the market trend analysis for oncofarma from 2024 to 2025. By examining various dimensions such as transaction quantity, transaction weight, average price, and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability. As of 2025, the company has completed 1 transactions, with a transaction quantity of 300 and a transaction weight of 0.
- Year Transactions Quantity Weight
- 2024 0 0 0
- 2025 1 300 0
Bill of lading data
< 1/1 >- Trade date 2025/10/17 B/L No. ——
- Suppliers arbiter health care Buyers oncofarma
- POLs chennai (ex madras) PODs maputo
- Supply area India Purchas area Mozambique
- Weight —— Amount 626400
- Hs code 30049099 Product tags ultravist,injection,iopromide
- Product description IOPROMIDE INJECTION USP ULTRAVIST 370MG100ML Expand
Partners
Total 1- Rank Company Transactions Per Detail
- 1 arbiter health care indiasupplier,they trade on 2025-10-17 1 100.00% >
Products
Total 3- Products Transactions Per Detail
-
injection
1 100% > -
iopromide
1 100% > -
ultravist
1 100% >
Hscode rank
Total 1- HSCode Name Transactions Per Detail
- HS 30049099 1 100% >
Trading Area
Total 1- Area Transactions Per Detail
- india 1 100.00% >
Port statistics
Total 1- Port Name Transactions Per Detail
- maputo 1 100.00% >